Consecutive drug price reductions of hyperlipidemia treatments, setting the price competition

Published: 2015-04-24 13:16:11

Updated: 2015-04-24 13:16:11

The price has been magnified from the competition among hyperlipidemia treatments as launches of new drug and the drug price reduction.

According to the recent official announcement of the Health and Welfare, the ceiling price of the insurance benefit of the MSD Korea’s hyperlipidemia complex ‘Atozet 10/10mg(generic name: ezetimib and atorvastatin)’ will decrease 21% down from KRW 1,394 to KRW...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.